MedTrace Logo

A Text-Based Expressive Writing Program for Adolescents at Risk of Suicide

NCT07479823 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-03-18

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a structured expressive writing program can help reduce suicidal thoughts in adolescents and young adults who have experienced suicidal thoughts, suicide attempts, or self-harm. The study will include participants aged 13 to 24 years who are receiving mental health care or have recently been identified as being at risk for suicide.

The main questions the study aims to answer are:

* Does a structured expressive writing program lower suicidal thoughts compared with usual care alone?
* Does the program improve depression, impulsivity, and self-esteem?

Researchers will compare participants who receive the expressive writing program together with treatment as usual to participants who receive treatment as usual alone.

Participants will:

* Be randomly assigned to one of two groups: a writing program group or a usual care group
* Complete questionnaires about mood, suicidal thoughts, and well-being at the start of the study, after 4 weeks, and after 8 weeks
* If assigned to the writing program group, complete guided writing activities several times per week for 4 weeks. Each writing session will take about 15 to 20 minutes and will focus on understanding emotions, personal experiences, relationships, and meaning in difficult experiences.

Researchers will study whether this writing program is a helpful and practical way to support young people who are experiencing suicidal thoughts or emotional distress.

Conditions

Interventions

BEHAVIORAL

Structured Expressive Writing Intervention

A structured expressive writing program in which participants complete guided writing sessions several times per week for four weeks. Each session lasts approximately 15 to 20 minutes and focuses on emotional awareness and personal reflection.

BEHAVIORAL

Treatment as Usual (TAU)

Participants receive the standard mental health care or support services that are normally available during the study period.

Sponsors & Collaborators

  • Hallym University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2027-12-31
Completion
2028-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07479823 on ClinicalTrials.gov